Regulators overseeing rare disease treatments need better tools to weigh competing risks in real time. Sarepta Therapeutics’ Elevidys is a prime example of why.
Researchers combined data from Temporal Experiment for Storms and Tropical Systems – Demonstration (TEMPEST-D), which provides horizontal observations of intense precipitation, with Radar in a Cubesat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results